CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. Electronic address: gusella@helix.mgh.harvard.edu; Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium.
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.
PMID:31398342
UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target.
Willemse SW, Harley P, van Eijk RPA, Demaegd KC, Zelina P, Pasterkamp RJ, van Damme P, Ingre C, van Rheenen W, Veldink JH, Kiernan MC, Al-Chalabi A, van den Berg LH, Fratta P, van Es MA.
Genetics of Polycystic Ovary Syndrome: What is New?
Welt CK.
Endocrinol Metab Clin North Am. 2021 Mar;50(1):71-82. doi: 10.1016/j.ecl.2020.10.006.
PMID:33518187
Genetic determinants of P wave duration and PR segment.
Verweij N, Mateo Leach I, van den Boogaard M, van Veldhuisen DJ, Christoffels VM; LifeLines Cohort Study; Hillege HL, van Gilst WH, Barnett P, de Boer RA, van der Harst P.